124 related articles for article (PubMed ID: 23938069)
1. A "glucose eater" drug as a therapeutic agent in psychiatry.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2013 Sep; 51(9):13-6. PubMed ID: 23938069
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and mental illness. Weight gain and other unhealthy attributes increase risk of diabetes and heart disease.
Harv Ment Health Lett; 2011 Aug; 28(2):5. PubMed ID: 21980633
[No Abstract] [Full Text] [Related]
4. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ellinger LK; Ipema HJ; Stachnik JM
Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
[TBL] [Abstract][Full Text] [Related]
6. Use of metformin in pediatric age.
Brufani C; Fintini D; Nobili V; Patera PI; Cappa M; Brufani M
Pediatr Diabetes; 2011 Sep; 12(6):580-8. PubMed ID: 21366813
[No Abstract] [Full Text] [Related]
7. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.
Hasnain M; Fredrickson SK; Vieweg WV
J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390
[TBL] [Abstract][Full Text] [Related]
8. Metformin in noninsulin-dependent diabetes mellitus.
Lee AJ
Pharmacotherapy; 1996; 16(3):327-51. PubMed ID: 8726592
[TBL] [Abstract][Full Text] [Related]
9. Metformin: an old drug with new potential.
Hajjar J; Habra MA; Naing A
Expert Opin Investig Drugs; 2013 Dec; 22(12):1511-7. PubMed ID: 23978196
[TBL] [Abstract][Full Text] [Related]
10. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
[TBL] [Abstract][Full Text] [Related]
11. Metformin therapy and diabetes in pregnancy.
Simmons D; Walters BN; Rowan JA; McIntyre HD
Med J Aust; 2004 May; 180(9):462-4. PubMed ID: 15115425
[TBL] [Abstract][Full Text] [Related]
12. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.
Veltkamp SA; van Dijk J; Collins C; van Bruijnsvoort M; Kadokura T; Smulders RA
Clin Ther; 2012 Aug; 34(8):1761-71. PubMed ID: 22795925
[TBL] [Abstract][Full Text] [Related]
14. Current indications for metformin therapy.
Tankova T
Rom J Intern Med; 2003; 41(3):215-25. PubMed ID: 15526505
[TBL] [Abstract][Full Text] [Related]
15. Diabetes control without weight gain.
Health News; 1999 Apr; 5(5):6. PubMed ID: 10214130
[No Abstract] [Full Text] [Related]
16. Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.
Lund A; Knop FK
Curr Med Res Opin; 2012 May; 28(5):731-6. PubMed ID: 22462528
[TBL] [Abstract][Full Text] [Related]
17. Gaining: pediatric patients and use of atypical antipsychotics.
Towbin KE
Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
[No Abstract] [Full Text] [Related]
18. Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues.
Andrade C
J Clin Psychiatry; 2016 Nov; 77(11):e1491-e1494. PubMed ID: 28076676
[TBL] [Abstract][Full Text] [Related]
19. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
20. Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiology.
Koliaki C; Doupis J
Adv Ther; 2012 Dec; 29(12):993-1004. PubMed ID: 23184570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
